Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Kennedy's disease leads to muscle weakness without a cure, but exercise and managing symptoms may help patients live a normal lifespan.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

G allele of AR Stul polymorphism linked to higher hair loss risk, especially in white people.

Using psychological treatments can help manage skin conditions along with regular medical care.

Loose Anagen Syndrome is a hair condition where hairs can be easily pulled out, mainly affecting young girls, and may improve on its own or with treatment.

Three new types of a skin blistering disease were found, caused by specific gene mutations.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Common acne treatments can cause various side effects, like skin irritation and more serious issues, but combination therapies are often more effective and better tolerated.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Topical minoxidil effectively and safely treats extensive alopecia areata but doesn't change its course.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

Finasteride effectively treats male hair loss, improving growth and density.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

Early hair loss may indicate prostate issues.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Ketoconazole shampoo with finasteride improves hair density in men with hair loss.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.